Recent Rates of Systemic Treatment for Metastatic NSCLC in Older Adults - Takeaways - MDSpire
From the Journals

Recent Rates of Systemic Treatment for Metastatic NSCLC in Older Adults

In a cohort study reported in JAMA Oncology, Fox et al found that approximately half of older patients with metastatic non–small cell lung cancer (NSCLC) have received systemic therapy in the United S...

  • By

  • Matthew Stenger

  • May 12, 2026

  • 3 min

Share

  • 1

    Study on older patients with metastatic NSCLC from 2006-

  • 2

    46.8% received systemic therapy; a slight increase noted until

  • 3

    Oncology referrals increase treatment likelihood significantly.

  • 4

    Patients over 80 had a lower treatment incidence.

  • 5

    Biomarker testing linked to higher systemic treatment uptake.

  • 6

    Significant racial and health coverage disparities noted.

  • 7

    Funding received from American Cancer Society and Amgen, Inc.

Original Source(s)

Recent Rates of Systemic Treatment for Metastatic NSCLC in Older Adults

  • by Matthew Stenger

  • May 12, 2026

Related Content

Flu Hospitalization Tied to Diabetes Risk

A large English cohort study found influenza hospitalization more than doubled the short-term risk of new-onset diabetes, with prediabetes and critical care admission among the strongest predictors.

E-Cigarette Devices Linked to Inhaled Metal Exposure 

Device-to-tissue mass spectrometry traces metal emissions from e-cigarette components into exposed lung sections

  • May 12, 2026

  • 3 min
Stewardship Cuts Steroid Prescribing

Behaviorally informed peer comparison feedback was associated with a gradual decline in glucocorticoid prescribing